Liver Lesions in Dolphins: The Role of Microcystin
Author Information
Author(s): Ami Krasner, Wendy Noke Durden, Megan Stolen, Teresa Jablonski, Agatha Fabry, Annie Page, Wendy Marks, Cecilia Costa, H. C. D. Marley, Spencer Fire, William S. Baldwin, Hartmut W. Jaeschke
Primary Institution: Florida Institute of Technology
Hypothesis
Does microcystin exposure contribute to liver lesions in bottlenose dolphins in the Indian River Lagoon?
Conclusion
The study found no evidence linking microcystin exposure to liver disease in bottlenose dolphins.
Supporting Evidence
- Microcystin was detected in 6% of samples screened from dolphins.
- Common liver anomalies included inflammation, fibrosis, and lipidosis.
- Ten dolphins tested positive for microcystin via ELISA, but none were confirmed by MMPB.
- Most liver lesions were not linked to microcystin exposure.
- Further investigation is needed to determine the causes of liver lesions.
Takeaway
Scientists looked at dolphins in Florida to see if a toxin called microcystin was making their livers sick, but they didn't find a clear link.
Methodology
The study reviewed histopathology reports and screened liver and fecal samples for microcystin using ELISA and MMPB techniques.
Limitations
The inability to confirm microcystin exposure through MMPB testing may indicate false positives or detection limits.
Participant Demographics
The study included 156 bottlenose dolphins, with 41% adults, 44% juveniles, and 15% calves.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website